secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0001104659-24-003706
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals dismisses EisnerAmper as auditor, appoints Marcum; cites material weaknesses
--------------------------------------------------------------------------------

- Audit committee dismissed EisnerAmper as independent auditor on January 8, 2024; engaged Marcum effective immediately.
- EisnerAmper's reports for FY2021 and FY2022 contained a going-concern paragraph due to net losses and negative cash flows.
- Material weaknesses in internal control identified for FY2021, FY2022, and Q1-Q3 2023: insufficient monitoring, segregation of duties, IT access.
- No disagreements with EisnerAmper on accounting principles or audit scope during the period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924003706/0001104659-24-003706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924003706/tm243065d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-003706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer